Esophageal Cancer
Esophageal Cancer
Advertisement
Tamara ThomasEsophageal Cancer | May 13, 2025
"PD-L1 inhibitors have significantly changed oncology [but] only about 30% of patients with cancer benefit from the drugs."
Read More
Tamara ThomasUrban Health Weekly | May 10, 2025
Dr. Andrew Hertler explains the FDA’s decision to narrow approvals for PD-1 inhibitors for stomach and esophageal cancers
Urban Health Today EditorsEsophageal Cancer | March 21, 2025
Dr. Hertler breaks down the FDA’s restricting PD-1 inhibitor drugs for PD-L1-negative stomach and esophageal cancers
Tamara ThomasEsophageal Cancer | March 17, 2025
Researchers selected representative groups for individuals with more than a 5% risk of developing BE or EC
Tamara ThomasColorectal Cancer | February 12, 2025
Individuals living in lower-income areas experience disproportionately higher rates of late-stage diagnoses and mortality.
Tamara ThomasEsophageal Cancer | January 30, 2025
Studies show that obesity is a risk factor for both Barrett's esophagus and esophageal cancer.
Tamara ThomasEsophageal Cancer | January 21, 2025
studies have identified important long-term risks of esophageal cancer, including tobacco, alcohol, and reflux esophagitis
Lou PorteroPublic Health | January 9, 2025
Despite mounting evidence that no level of alcohol consumption is safe many people are unaware of the risks.
Advertisement
Advertisement
Latest News

May 29, 2025